Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group
about
High prevalence of SLC6A8 deficiency in X-linked mental retardationClinical and molecular delineation of the 17q21.31 microdeletion syndromeFragile X syndrome: the FMR1 CGG repeat distribution among world populationsThe fragile X gene and its functionMouse genetic models for prepulse inhibition: an early reviewThe fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95.Investigation of children with "developmental delay".Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities.Prevalence estimation of Williams syndrome.High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction techniqueDiagnostic genome profiling in mental retardation.Hypomethylation of an expanded FMR1 allele is not associated with a global DNA methylation defect.A combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trialSplitting and lumping in the nosology of XLMR.FMRP detection assay for the diagnosis of the fragile X syndrome.FMR1 and the fragile X syndrome: human genome epidemiology reviewPrevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.Noninvasive test for fragile X syndrome, using hair root analysis.Is synaesthesia an X-linked dominant trait with lethality in males?Different approaches to relating genotype to phenotype in developmental disorders.Insular volume reduction in fragile X syndromeFragile X mental retardation protein in plasticity and disease.Telomeres: a diagnosis at the end of the chromosomesScreening for the fragile X syndrome among the mentally retarded: a clinical study. The Collaborative Fragile X Study Group.FRAXA and FRAXE: the results of a five year survey.Clinical studies on submicroscopic subtelomeric rearrangements: a checklist.Prospective screening for subtelomeric rearrangements in children with mental retardation of unknown aetiology: the Amsterdam experience.Diagnostic investigations in individuals with mental retardation: a systematic literature review of their usefulness.3D pattern of brain abnormalities in Fragile X syndrome visualized using tensor-based morphometry.Identification of expanded alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) study.X linked mental retardation: a clinical guide.A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardationSavings and extinction of conditioned eyeblink responses in fragile X syndrome.Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population.Effects of stimulus salience on touchscreen serial reversal learning in a mouse model of fragile X syndrome.Role of hippocampal NMDA receptors in a mouse model for fragile X mental retardation syndrome.Eyeblink conditioning: a non-invasive biomarker for neurodevelopmental disorders.Synaptic vesicle dynamic changes in a model of fragile X.
P2860
Q24533559-661DE599-76D5-4671-B845-62F13F9F2D9CQ24624737-CD26E0DE-B937-466D-8BD2-0302876E50F7Q24629837-613DEEFF-AA30-4A98-B657-424B05C5A4E5Q28201533-56AE92FF-091D-4582-A512-A42D82F638CFQ28217163-59DF7688-2906-4109-8437-9BC18D556A60Q33717210-E68EEBA6-2B64-4F81-B8D9-FE719B37575CQ33729532-FB24C099-9FDF-4204-86C7-56DEF2911A17Q33905292-E7D7495E-9CBE-4D40-A821-206D71A31DA5Q33959905-26FA2ACE-F035-42CE-BF40-43DD775A534DQ34112106-5151841B-1DFC-47CE-A79D-36F4D85A2129Q34114527-A6243454-5FCA-41C2-B182-CFD5D2C50DC0Q34145956-3CDB1422-2517-49E8-8DDD-CE5E1EDEE5ACQ34207747-A73AD015-2C40-4E8A-BA0D-5FA209C20EDAQ34306122-B084401B-8CF8-42B5-BFE3-58D402EADD41Q34306129-2AB47D9D-F581-4E79-8AE4-B0A36A91E386Q34362009-A5CBCB2C-6C89-4420-8FBF-FA9136B9C973Q34388858-40FF905B-1B69-40E1-A167-4EF2585E5D88Q34390773-CC61FB79-D519-4CF9-82DC-EBCE166010DDQ34430356-60D85A63-0F1E-485A-98A2-677C3FD61387Q34561421-BEA7206B-E973-4078-AD02-3E79C51C79EFQ34984581-1180D86A-191C-417D-B368-D9CAB65CC007Q34993137-AC390186-DE96-4DA3-AF32-B31F3AC6C964Q35154981-DF58F5EF-4F6D-4EC2-A798-44377AB6BE38Q35432727-5D534374-4BF5-484E-8F30-9E21DDFCD496Q35434914-A09DA35E-D20E-497F-AB6D-70F3DFB22341Q35437015-536FDD02-81BE-4B98-83E9-621B44FB85A7Q35440261-67A5BFA3-BEDA-4275-A6F1-7332B9958852Q35938000-9222087B-FCFA-47A8-8E47-54F4F1A23291Q36016303-27248385-1141-402D-AF62-46D673CE5723Q36132963-AD11A1FC-3385-478B-A3F5-AE55304E097EQ36239035-31FE8CCB-20F1-4EDC-B594-909CF5084012Q36329311-391A6017-4F4E-4488-B914-F64B0001E8D1Q36379639-FE315B50-D2A8-41CA-B4A0-087D5AFA6436Q36430804-8173B8D1-461F-4758-B6B6-2C149CF0BA81Q37035444-8B1A2775-86FC-47CC-AB30-FA31894E4F35Q37261871-E6A770E7-02C5-4608-B552-C0206EB694A1Q37372367-0155D8F4-3AC9-4D72-BDDA-B5E5BD0AAE82Q37393629-5A3D63B7-2A7E-4759-9BC5-407C1C6AEDE4Q38128728-84615FAF-357E-491C-BEEB-D1A3BF44568EQ38693916-AE1A6AB8-E3CA-4D9F-8E6B-C79D0DB05A44
P2860
Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Screening and diagnosis for th ...... borative Fragile X Study Group
@ast
Screening and diagnosis for th ...... borative Fragile X Study Group
@en
type
label
Screening and diagnosis for th ...... borative Fragile X Study Group
@ast
Screening and diagnosis for th ...... borative Fragile X Study Group
@en
prefLabel
Screening and diagnosis for th ...... borative Fragile X Study Group
@ast
Screening and diagnosis for th ...... borative Fragile X Study Group
@en
P2093
P2860
P356
P1476
Screening and diagnosis for th ...... borative Fragile X Study Group
@en
P2093
A M van den Ouweland
B A Oostra
B B de Vries
D J Halley
H J Duivenvoorden
L A Sandkuijl
M F Niermeijer
M van Rijn
P2860
P304
P356
10.1086/515496
P407
P50
P577
1997-09-01T00:00:00Z